Gijtenbeek RGP, et al. Treatment tolerance and survival in elderly patients with stage IV non-small cell lung cancer (NSCLC). P4658. ERS 2019, 30 sept, Madrid, Spanje.
Behandeling stadium II-III niet-kleincellig longcarcinoom gaat flink op de schop
apr 2024 | Immuuntherapie, Longoncologie